Outlook Therapeutics Investors: Company Investigated by the Portnoy Law Firm
January 02, 2024 22:18 ET
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Jan. 02, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Outlook Therapeutics, Inc....
OTLK STOCK ALERT: Robbins LLP Reminds Investors of January 2, 2024, Lead Plaintiff Deadline in the Class Action Filed Against Outlook Therapeutics, Inc.
December 15, 2023 19:03 ET
|
Robbins LLP
Outlook Therapeutics, Inc. (OTLK) Misled Investors About the Viability and Efficacy of its Lead Product Candidate
OTLK STOCK NEWS: Investors with Significant Losses in Outlook Therapeutics, Inc. Should Contact Robbins LLP for Information About the Outlook Therapeutics, Inc. Class Action
November 21, 2023 16:52 ET
|
Robbins LLP
Outlook Therapeutics, Inc. (OTLK) Misled Investors About the Viability and Efficacy of its Lead Product Candidate
OUTLOOK THERAPEUTICS INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Outlook Therapeutics Investors of a Class Action Lawsuit and Upcoming Deadline
November 16, 2023 10:34 ET
|
Kaplan Fox & Kilsheimer LLP
Kaplan Fox reminds investors that a complaint has been filed on behalf of investors that purchased or otherwise acquired Outlook Therapeutics.
OTLK Class Action Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in the Outlook Therapeutics, Inc. Class Action
November 13, 2023 18:08 ET
|
Robbins LLP
Outlook Therapeutics, Inc. (OTLK) Misled Investors About the Viability and Efficacy of its Lead Product Candidate
Shareholder Alert: Robbins LLP Informs Shareholders of Class Action Filed Against Outlook Therapeutics, Inc. (BCS)
November 07, 2023 13:03 ET
|
Robbins LLP
Outlook Therapeutics, Inc. (OTLK) Misled Investors About the Viability and Efficacy of its Lead Product Candidate
Outlook Therapeutics Investors: Company Investigated by the Portnoy Law Firm
October 17, 2023 17:22 ET
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Oct. 17, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Outlook Therapeutics, Inc....
Outlook Therapeutics Investors: Company Investigated by the Portnoy Law Firm
October 11, 2023 17:49 ET
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Oct. 11, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Outlook Therapeutics, Inc....